buthionine sulfoximine has been researched along with artenimol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dodd, CC; Edwards, G; McLean, WG; Park, BK; Sadler, CJ; Smith, SL; Ward, SA | 1 |
| Gong, S; Hu, Y; Lu, M; Luo, Y; Ma, XN; Tian, J; Wu, Y; Xu, Z; Yu, BY; Yu, XA; Zhang, Y | 1 |
2 other study(ies) available for buthionine sulfoximine and artenimol
| Article | Year |
|---|---|
The role of glutathione in the neurotoxicity of artemisinin derivatives in vitro.
Topics: Animals; Antimalarials; Antimetabolites; Antioxidants; Artemether; Artemisinins; Buthionine Sulfoximine; Drug Interactions; Glutathione; Hemin; Humans; Mice; Neurites; Sesquiterpenes; Tumor Cells, Cultured | 2001 |
A cancer-specific activatable theranostic nanodrug for enhanced therapeutic efficacy via amplification of oxidative stress.
Topics: Animals; Artemisinins; Buthionine Sulfoximine; Drug Carriers; Female; Glutathione; Hep G2 Cells; Humans; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Oxidation-Reduction; Oxidative Stress; Precision Medicine; Reactive Oxygen Species; Transferrin | 2020 |